What’s next for HIV Prevention for Women: VOICE-ing the need for FACTS

February 4, 2015 - AVAC

Today the Microbicide Trials Network (MTN) research team published the final VOICE trial results in the New England Journal of Medicine with findings that add urgency, and perhaps optimism, to the women's HIV prevention field as it counts the days until the late-February release of data from the FACTS 001 trial of the 1% tenofovir microbicide gel. (There is also a journal commentary entitled Preventing HIV in Women — Still Trying to Find Their VOICE.)

How does a publication of a trial that reported its results two years ago (and ended gel randomization and placebo control three years ago) raise the stakes today? To answer that question, it helps to look back at VOICE's design and findings to date. Continue reading...

0

Comments

0 comments

Image

Members of The Well Project community at USCHA 2022.

Become a Member

Join our community and become a member to find support and connect to other women living with HIV.

Join now >

Do you get our newsletter?

¿Recibe nuestro boletín?

Sign up for our monthly Newsletter and get the latest info in your inbox.

Suscríbase a nuestro boletín mensual y reciba la información más reciente en su bandeja de entrada.

banner

Hands of various skin tones linking pinky to thumb in a row.

Did you just test HIV+?

Newly diagnosed with HIV and not sure what to do? You are not alone.

Get help & information >

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>